Abstract:Objective To compare the efficacy and safety of atorvastatin,rosuvastatin and xuezhikang capsule in elderly.Methods A total of 314 60-to-94-year-old (average (73.6 ± 7.9) years old) patients who were given different doses and types of statins were divided into three groups:the atorvastatin group (108 patients),the rosuvastatin group (104 patients) and the xuezhikang capsule group (102 patients).The serum TG,TC,LDL-C,HDL-C,ALT and CK were examined before and after the treatment which lasted for at least 4 weeks.All patients were divided into moderate risk group (13,12 and 21 patients respectively in 3 groups) ; high risk group (40,44 and 48 patients respectively in 3 groups) and very high risk group (55,48 and 33 patients respectively in 3 groups) according to guidelines on prevention and treatment of dyslipidemia in chinese adults (2007 version).The rate of reaching target goal and the dose when reaching target levels in different risk stratification groups were calculated and compared.Results Serum TC,LDL-C and non-HDL-C were significantly reduced after the 4-week-treatment in all the three groups (P ＜ 0.01).Serum LDL-C level before and after treatment were (3.14 ± 0.78) mmol/L vs.(2.14 ±0.65) mmol/L in atorvastatin group (the arevage dose was (16.4 ± 4.8) mg/d),(2.92 ± 0.77)mmol/L vs.(1.96 ±0.55) mmol/L in rosuvastatin group (the arevage dose was (8.7 ±3.0) mg/d),and (2.70 ±0.62) mmol/L vs.(2.16 ±0.61) mmol/L in xuezhikang capsule group (the arevage dose was (0.9 ± 0.3) g/d).Among all the three groups of patients,the cases of reaching target levels of LDL-C were 13,11 and 20 in patients at moderate risk,were 38(95.0％),38(86.4％) and 40 (83.3％) in patients at high risk,and were 22(40.0％),30(62.5％) and 17(51.5％) in patients at very high risk.There were no statistical differences in the rate of reaching target levels of LDL-C,non-HDL-C and TC in the three groups and at different risks (P ＞ 0.05).One patient in the atorvastatin group showed ALT level elevation ＞ 3 times of the upper limit of normal value,there was no patient with CK level elevation ＞ 5 times of the upper limit of normal value.Conclusion Atorvastatin,rosuvastatin and xuezhikang capsule at low dose and/or standard dose are effective and safety in elderly patients.

The Therapeutic Efficacy and Safety of Different Statins in Elderly

The Effect of Atorvastatin on Lowering Lipids in Elderly Patients with Type 2 Diabetic Mellitus Plus Hyperlipidemia

Efficacy and safety comparison of different statins in elderly patients

Clinical Study for Dose-Effect and Safety of Rosuvastatin in Patients with Primary Hypercholesterolemia

Association of Lipid-Lowing Efficacy and Safety of Short-Term Statins Therapy with Different Dosages

Efficacy And Safety Of Fenofibrate As An Add-On In Patients With Elevated Triglyceride Despite Receiving Statin Treatment

The efficacy and safety of different doses of simvastatin in treatment of patients with coronary artery disease

Effects of atorvastatin on atherosclerotic plaques in elderly patients with hyperlipoidemia

Evaluation for the Efficacy of Taizhian in Treatment of Primary Hyperlipidemia in Aged Patients

Efficacy and safety of rosuvastatin in the treatment of hypercholesterolemia

Clinical observation in therapy on primary mixed hyperlipidaemia of elderly patients

Effects of Statins on the Liver: Clinical Analysis of Patients with Ischemic Stroke

[Pravastatin: efficacy and safety in elderly patients with primary hypercholesterolemia. Open multicenter study].

Statins therapy in the elderly:a review on treatment of dyslipidemia

Assessing the effect of high-dose rosuvastatin in elderly patients over 75 with acute coronary syndrome

Advances of lipid-lowering therapy in the elderly

Infulence of factors related to statin-induced alanine aminofransferase abnormalities in elderly patients

Meta-analysis of the Efficacy and Safety of Simvastatin vs. Pravastatin in the Treatment of Hyperlipidemia

Multi-center Study of Efficacy and Safety of Atorvastatin 20 Mg in Chinese Coronary Heart Disease Patients with Hyperlipidemia

Short-term efficacy of different statins in treatment of patients with nonalcoholic fatty liver disease and hyperlipidaemia

Study of Intervention with Atorvastatin and Simvastatin on Carotid Atherosclerosis in Old Patients